1. Home
  2. USA vs MNKD Comparison

USA vs MNKD Comparison

Compare USA & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$6.12

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.48

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
MNKD
Founded
1986
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
USA
MNKD
Price
$6.12
$5.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$10.08
AVG Volume (30 Days)
880.5K
3.7M
Earning Date
01-01-0001
02-25-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
23.47
EPS
N/A
0.10
Revenue
N/A
$313,787,000.00
Revenue This Year
N/A
$21.40
Revenue Next Year
N/A
$25.03
P/E Ratio
N/A
$55.78
Revenue Growth
N/A
17.43
52 Week Low
$5.62
$3.38
52 Week High
$7.09
$6.51

Technical Indicators

Market Signals
Indicator
USA
MNKD
Relative Strength Index (RSI) 38.27 46.52
Support Level $6.22 $5.03
Resistance Level $6.33 $6.05
Average True Range (ATR) 0.06 0.29
MACD -0.03 -0.02
Stochastic Oscillator 1.58 35.04

Price Performance

Historical Comparison
USA
MNKD

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: